Vigil Neuroscience Inc. (VIGL)
NASDAQ: VIGL
· Real-Time Price · USD
2.77
0.21 (8.20%)
At close: May 02, 2025, 12:29 PM
8.20% (1D)
| Bid | 2.72 |
| Market Cap | 129.28M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -84.26M |
| EPS (ttm) | -2.07 |
| PE Ratio (ttm) | -1.34 |
| Forward PE | -1.33 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 158,446 |
| Avg. Volume (20D) | 227,025 |
| Open | 2.46 |
| Previous Close | 2.56 |
| Day's Range | 2.46 - 2.78 |
| 52-Week Range | 1.31 - 6.06 |
| Beta | 1.95 |
About VIGL
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy wi...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 7, 2022
Employees 69
Stock Exchange NASDAQ
Ticker Symbol VIGL
Website https://www.vigilneuro.com
Analyst Forecast
According to 5 analyst ratings, the average rating for VIGL stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 405.42% from the latest price.
Stock Forecasts1 month ago
-6.81%
Vigil Neuroscience shares are trading lower. The c...
Unlock content with
Pro Subscription
1 month ago
-10.21%
Vigil Neuroscience shares are trading lower after the company a Q4 GAAP EPS miss.
